Yn dangos 1666 i 1680 o 1999 canlyniadau
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Policy statement on HCPC’s approach to developing memorandums of understanding
This policy statement sets out our broad approach to developing memorandums of understanding (MoUs) with other organisations.